Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-News: 1&1 AG: First European mobile network based on innovative OpenRAN technology successfully launched: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24057/Drillisch_AG_Logo.svg.png
EQS-News: 1&1 AG: First European mobile network based on innovative OpenRAN technology successfully launched
EQS-News: 1&1 AG: First European mobile network based on innovative OpenRAN technology successfully launched
eqs_en 
0 03.01.23
EQS-Adhoc: Brenntag SE terminates preliminary discussions with Univar Solutions Inc.: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23703/Brenntag.svg.png
EQS-Adhoc: Brenntag SE terminates preliminary discussions with Univar Solutions Inc.
EQS-Adhoc: Brenntag SE terminates preliminary discussions with Univar Solutions Inc.
eqs_en 
0 02.01.23
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
eqs_en 
0 30.12.22
EQS-News: GRENKE concludes purchase agreements for four more franchise companies : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24105/Grenke_Logo.jpg
EQS-News: GRENKE concludes purchase agreements for four more franchise companies
EQS-News: GRENKE concludes purchase agreements for four more franchise companies
eqs_en 
0 29.12.22
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
eqs_en 
0 29.12.22
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
eqs_en 
0 28.12.22
The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
The Vanguard Group, Inc.: Horizon Therapeutics plc
The Vanguard Group, Inc.: Horizon Therapeutics plc
eqs_en 
0 27.12.22
EQS-Adhoc: HELLA GmbH & Co. KGaA: Consensual termination with the members of the Management Board Mr. Björn Twiehaus and Dr. Lea Corzilius: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23717/225px-HELLA_Logo_3D_Background_4C_300dpi.jpg
EQS-Adhoc: HELLA GmbH & Co. KGaA: Consensual termination with the members of the Management Board Mr. Björn Twiehaus and Dr. Lea Corzilius
EQS-Adhoc: HELLA GmbH & Co. KGaA: Consensual termination with the members of the Management Board Mr. Björn Twiehaus and Dr. Lea Corzilius
eqs_en 
0 23.12.22
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
eqs_en 
0 23.12.22
TUI AG: Director Declaration: https://upload.wikimedia.org/wikipedia/commons/1/1c/TUI_Logo_neu.png
TUI AG: Director Declaration
TUI AG: Director Declaration
eqs_en 
0 22.12.22
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
eqs_en 
0 22.12.22
SREP capital requirements for Commerzbank remain unchanged for 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23454/Commerzbank_%282009%29.svg.png
SREP capital requirements for Commerzbank remain unchanged for 2023
SREP capital requirements for Commerzbank remain unchanged for 2023
eqs_en 
0 22.12.22
EQS-News: SREP capital requirements for Commerzbank remain unchanged for 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23454/Commerzbank_%282009%29.svg.png
EQS-News: SREP capital requirements for Commerzbank remain unchanged for 2023
EQS-News: SREP capital requirements for Commerzbank remain unchanged for 2023
eqs_en 
0 22.12.22
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
eqs_en 
0 21.12.22
EQS-News: 1&1 AG: 1&1 concludes contract for the acquisition of up to 7,500 new antenna locations : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24057/Drillisch_AG_Logo.svg.png
EQS-News: 1&1 AG: 1&1 concludes contract for the acquisition of up to 7,500 new antenna locations
EQS-News: 1&1 AG: 1&1 concludes contract for the acquisition of up to 7,500 new antenna locations
eqs_en 
0 21.12.22
EQS-News: 1&1 AG: 1&1 concludes contract for the acquisition of up to 7,500 new antenna locations : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24057/Drillisch_AG_Logo.svg.png
EQS-News: 1&1 AG: 1&1 concludes contract for the acquisition of up to 7,500 new antenna locations
EQS-News: 1&1 AG: 1&1 concludes contract for the acquisition of up to 7,500 new antenna locations
eqs_en 
0 21.12.22
EQS-News: Aurubis AG: Aurubis closes fiscal year with the best result in the company's history : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23699/Aurubis-Logo.svg.png
EQS-News: Aurubis AG: Aurubis closes fiscal year with the best result in the company's history
EQS-News: Aurubis AG: Aurubis closes fiscal year with the best result in the company's history
eqs_en 
0 21.12.22
EQS-News: Chief Financial Officer Sung Lee to Leave MorphoSys in March 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: Chief Financial Officer Sung Lee to Leave MorphoSys in March 2023
EQS-News: Chief Financial Officer Sung Lee to Leave MorphoSys in March 2023
eqs_en 
0 20.12.22
EQS-News: Chief Financial Officer Sung Lee to Leave MorphoSys in March 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: Chief Financial Officer Sung Lee to Leave MorphoSys in March 2023
EQS-News: Chief Financial Officer Sung Lee to Leave MorphoSys in March 2023
eqs_en 
0 20.12.22
EQS-News: Aurubis AG: Aurubis adopts € 530 million investment package to accelerate growth and sustainability: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23699/Aurubis-Logo.svg.png
EQS-News: Aurubis AG: Aurubis adopts € 530 million investment package to accelerate growth and sustainability
EQS-News: Aurubis AG: Aurubis adopts € 530 million investment package to accelerate growth and sustainability
eqs_en 
0 20.12.22
EQS-Adhoc: Aurubis AG: Supervisory Board approves comprehensive growth package and adjusts dividend policy: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23699/Aurubis-Logo.svg.png
EQS-Adhoc: Aurubis AG: Supervisory Board approves comprehensive growth package and adjusts dividend policy
EQS-Adhoc: Aurubis AG: Supervisory Board approves comprehensive growth package and adjusts dividend policy
eqs_en 
0 20.12.22
EQS-News: Brenntag SE receives letter from PrimeStone Capital LLP: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23703/Brenntag.svg.png
EQS-News: Brenntag SE receives letter from PrimeStone Capital LLP
EQS-News: Brenntag SE receives letter from PrimeStone Capital LLP
eqs_en 
0 20.12.22
TUI AG: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them: https://upload.wikimedia.org/wikipedia/commons/1/1c/TUI_Logo_neu.png
TUI AG: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
TUI AG: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
eqs_en 
0 20.12.22
EQS-News: Supervisory Board appoints Dr. Michael Heckmeier as future CEO of Siltronic AG: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24068/Siltronic_Logo.svg.png
EQS-News: Supervisory Board appoints Dr. Michael Heckmeier as future CEO of Siltronic AG
EQS-News: Supervisory Board appoints Dr. Michael Heckmeier as future CEO of Siltronic AG
eqs_en 
0 20.12.22
EQS-News: Supervisory Board appoints Dr. Michael Heckmeier as future CEO of Siltronic AG: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24068/Siltronic_Logo.svg.png
EQS-News: Supervisory Board appoints Dr. Michael Heckmeier as future CEO of Siltronic AG
EQS-News: Supervisory Board appoints Dr. Michael Heckmeier as future CEO of Siltronic AG
eqs_en 
0 20.12.22